WynnVision LLC Receives NIH NIDDK Phase IIB Grant Award for Biofilm Resistant Coatings on Indwelling Urinary Catheters
Summary
RICHMOND, VA, UNITED STATES, July 7, 2023/EINPresswire.com/ -- NIHs National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded WynnVision a Phase IIB Grant Toward urinary catheterization with long-term resistance to bacterial colonization (R44DK103398). (1) Work supported by this grant will focus on development of novel coatings that reduce bacterial biofilm formation on silicone medical devices. These qualities promise to reduce CAUTIs, patient suffering, and medical care costs.Kenneth Wynne, PhD, President of WynnVision LLC, is an established researcher who retired in 2019, becoming Commonwealth Professor Emeritus, Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond VA. Ken has helped raise about $5 M in grant funding and guided WynnVision scientists and engineers toward achieving challenging research objectives. His experience has included tailoring surfaces to obtain specific properties such as repelling ice, killing bacteria on contact, or releasing biologically active agents. Ken founded WynnVision LLC in 2016 to translate his experience in surface modification at the molecular level into products for relieving pain and suffering for patients due to adverse events associated with medical devices.